New Delhi, Jan 02: An expert panel of India's Central Drug Authority has recommended granting permission for restricted emergency use of Oxford-AstraZeneca vaccine Covishield, being manufactured by the Serum Institute of India, paving the way for the roll-out of the first
from India News, India Breaking News, Latest news headlines in India - Oneindia News https://ift.tt/38848sf
from India News, India Breaking News, Latest news headlines in India - Oneindia News https://ift.tt/38848sf
ConversionConversion EmoticonEmoticon